Zevenbergen Capital Investments LLC Purchases 207,157 Shares of Rocket Lab Corporation $RKLB

Key Points

• Zevenbergen Capital Investments increased its Rocket Lab position by 20.6%, buying 207,157 shares to reach 1.21 million shares worth approximately $84.5 million. Institutional investors and hedge funds collectively own 71.78% of the company.
• Rocket Lab shares traded at $68.40, with a market capitalization of about $40.9 billion and a one-year range of $37.57 to $151.00. The company remains unprofitable after missing quarterly EPS estimates, although revenue of $234.1 million exceeded expectations.
• Analyst sentiment is broadly positive, with a consensus “Moderate Buy” rating and a $106.14 target price, but investors face risks from the company’s speculative valuation, continued insider selling, potential dilution, and execution challenges surrounding the Neutron rocket and proposed Iridium transaction.

Zevenbergen Capital Investments LLC lifted its position in Rocket Lab Corporation (NASDAQ:RKLB - Free Report) by 20.6% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,212,160 shares of the rocket manufacturer's stock after purchasing an additional 207,157 shares during the quarter. Rocket Lab comprises 1.9% of Zevenbergen Capital Investments LLC's holdings, making the stock its 18th largest position. Zevenbergen Capital Investments LLC owned approximately 0.20% of Rocket Lab worth $84,463,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of RKLB. BlackRock Inc. purchased a new position in Rocket Lab during the 2nd quarter worth approximately $4,124,970,000. Bank of America Corp DE purchased a new stake in shares of Rocket Lab in the 2nd quarter valued at $437,280,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in shares of Rocket Lab by 14.8% in the 2nd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,737,451 shares of the rocket manufacturer's stock valued at $278,262,000 after acquiring an additional 352,094 shares during the last quarter. Bank of New York Mellon Corp acquired a new stake in shares of Rocket Lab in the second quarter worth $245,764,000. Finally, Amundi increased its stake in shares of Rocket Lab by 22.2% in the second quarter. Amundi now owns 2,180,748 shares of the rocket manufacturer's stock worth $221,673,000 after acquiring an additional 396,639 shares during the period. Institutional investors and hedge funds own 71.78% of the company's stock.

Rocket Lab Price Performance

Shares of NASDAQ:RKLB traded down $3.52 during midday trading on Thursday, reaching $68.40. 22,944,104 shares of the company's stock traded hands, compared to its average volume of 23,079,742. The company has a fifty day simple moving average of $70.38 and a two-hundred day simple moving average of $84.43. Rocket Lab Corporation has a 1 year low of $37.57 and a 1 year high of $151.00. The company has a market cap of $40.93 billion, a P/E ratio of -253.32 and a beta of 2.93. The company has a debt-to-equity ratio of 0.01, a quick ratio of 4.98 and a current ratio of 5.48.

Rocket Lab (NASDAQ:RKLB - Get Free Report) last posted its quarterly earnings data on Monday, August 10th. The rocket manufacturer reported ($0.08) earnings per share for the quarter, missing analysts' consensus estimates of ($0.06) by ($0.02). The company had revenue of $234.07 million for the quarter, compared to analyst estimates of $231.62 million. Rocket Lab had a negative return on equity of 6.48% and a negative net margin of 21.51%. Equities analysts predict that Rocket Lab Corporation will post -0.2 EPS for the current fiscal year.

Insider Activity

In other Rocket Lab news, CFO Adam C. Spice sold 140,157 shares of the business's stock in a transaction that occurred on Thursday, October 1st. The stock was sold at an average price of $70.82, for a total transaction of $9,925,918.74. Following the completion of the sale, the chief financial officer directly owned 1,155,967 shares in the company, valued at approximately $81,865,582.94. The trade was a 10.81% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Arjun Kampani sold 7,754 shares of the business's stock in a transaction that occurred on Monday, August 24th. The stock was sold at an average price of $69.63, for a total value of $539,911.02. Following the sale, the senior vice president owned 256,951 shares of the company's stock, valued at approximately $17,891,498.13. This trade represents a 2.93% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last 90 days, insiders have sold 400,749 shares of company stock worth $26,964,474. Company insiders own 8.40% of the company's stock.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on RKLB shares. Berenberg Bank initiated coverage on shares of Rocket Lab in a research report on Wednesday, September 2nd. They set a "buy" rating and a $83.00 target price for the company. Citizens Jmp reaffirmed a "market outperform" rating and set a $130.00 price target on shares of Rocket Lab in a research report on Tuesday, August 11th. Weiss Ratings reiterated a "sell (d-)" rating on shares of Rocket Lab in a research note on Friday, July 17th. Morgan Stanley reissued an "overweight" rating on shares of Rocket Lab in a report on Wednesday, July 8th. Finally, Roth Capital set a $110.00 target price on Rocket Lab in a research note on Tuesday, August 11th. Four investment analysts have rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Rocket Lab currently has an average rating of "Moderate Buy" and a consensus price target of $106.14.

Key Headlines Impacting Rocket Lab

Here are the key news stories impacting Rocket Lab this week:

• Positive Sentiment: Potential NASA launch contracts: NASA has identified Rocket Lab’s Neutron rocket as a potential provider for bulk launches supporting its planned lunar-base program. Multi-year contracts could provide meaningful future revenue, although Neutron has not yet flown and no award has been finalized. Rocket Lab Fell Hard Over The Last 3 Months: Wall Street Pro Predicts It Doubles From Today
• Positive Sentiment: Iridium acquisition could expand earnings: Rocket Lab canceled its planned $3.6 billion bridge loan and fully funded the transaction through debt and equity financing. Iridium’s approximately $500 million in annual EBITDA could substantially improve Rocket Lab’s earnings profile if the deal closes successfully. Rocket Lab: Iridium Could Explode EBITDA, But A Wildcard Decides If It’s Worth It
• Positive Sentiment: Analysts remain bullish: Recent coverage highlights more than 35% potential upside, while one analyst reiterated a target implying the stock could roughly double. Rocket Lab also has launch contracts extending through 2031, supporting the long-term investment case. 3 Space Stocks with More Than 35% Upside, According to Analysts
• Neutral Sentiment: Sector-wide pressure: Rocket Lab declined alongside other space companies, including Planet Labs and Intuitive Machines, suggesting part of the move reflects profit-taking and risk reduction across the sector rather than a new operational failure at Rocket Lab. AST SpaceMobile Sinks as Satellite Rival Clears Regulatory Hurdle
• Negative Sentiment: Dilution and insider-selling concerns: The Iridium financing may add as many as 72 million shares, while Rocket Lab has disclosed substantial equity issuance and continued insider selling. Those factors can weigh on per-share value and investor confidence.
• Negative Sentiment: Execution and valuation risks: Rocket Lab recently missed quarterly EPS expectations, remains unprofitable, and trades at a highly speculative valuation. Investors are also monitoring regulatory approvals and closing risks for the Iridium transaction, as well as the unflown Neutron rocket.

Rocket Lab Company Profile

Rocket Lab USA, Inc is a space and launch company that provides launch services, spacecraft, satellite components and other space systems for commercial, civil and national-security customers. The company designs and manufactures many of its products in-house, supporting missions from initial spacecraft development through launch and on-orbit operations.

Rocket Lab's primary launch vehicle is Electron, a small-lift rocket designed to place satellites into low Earth orbit. The company also operates the HASTE suborbital test platform for hypersonic and other advanced aerospace technologies and is developing Neutron, a larger reusable rocket intended to serve commercial and government missions.

Want to see what other hedge funds are holding RKLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Rocket Lab Corporation (NASDAQ:RKLB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.